179 related articles for article (PubMed ID: 29123445)
1. Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
Kishaba T
Eurasian J Med; 2017 Oct; 49(3):204-206. PubMed ID: 29123445
[TBL] [Abstract][Full Text] [Related]
2. Acute exacerbation of idiopathic pulmonary fibrosis triggered by
Suzuki A; Kimura T; Kataoka K; Matsuda T; Yokoyama T; Mori Y; Kondoh Y
Respir Med Case Rep; 2018; 23():103-106. PubMed ID: 29719792
[TBL] [Abstract][Full Text] [Related]
3. Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
Kishaba T
Medicina (Kaunas); 2019 Mar; 55(3):. PubMed ID: 30884853
[TBL] [Abstract][Full Text] [Related]
4. Acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF): an overview of current and future therapeutic strategies.
Biondini D; Balestro E; Sverzellati N; Cocconcelli E; Bernardinello N; Ryerson CJ; Spagnolo P
Expert Rev Respir Med; 2020 Apr; 14(4):405-414. PubMed ID: 31994940
[No Abstract] [Full Text] [Related]
5. Outcomes with newly proposed classification of acute respiratory deterioration in idiopathic pulmonary fibrosis.
Teramachi R; Kondoh Y; Kataoka K; Taniguchi H; Matsuda T; Kimura T; Yokoyama T; Yamano Y; Furukawa T; Sakamoto K; Hashimoto N; Hasegawa Y
Respir Med; 2018 Oct; 143():147-152. PubMed ID: 30261987
[TBL] [Abstract][Full Text] [Related]
6. Study protocol: exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebo-controlled, multi-center phase III trial (EXAFIP).
Naccache JM; Montil M; Cadranel J; Cachanado M; Cottin V; Crestani B; Valeyre D; Wallaert B; Simon T; Nunes H
BMC Pulm Med; 2019 Apr; 19(1):75. PubMed ID: 30971235
[TBL] [Abstract][Full Text] [Related]
7. Acute exacerbation of idiopathic pulmonary fibrosis induced by pertussis: the first case report.
Hirai K; Homma T; Yamaguchi F; Yamaguchi M; Suzuki S; Tanaka A; Ohnishi T; Sagara H
BMC Pulm Med; 2019 Jan; 19(1):15. PubMed ID: 30642317
[TBL] [Abstract][Full Text] [Related]
8. Time for Prevention of Idiopathic Pulmonary Fibrosis Exacerbation.
Richeldi L
Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2():S181-5. PubMed ID: 26595737
[TBL] [Abstract][Full Text] [Related]
9. Clinical Characteristics Based on the New Criteria of Acute Exacerbation in Patients with Idiopathic Pulmonary Fibrosis.
Kishaba T; Nei Y; Momose M; Nagano H; Yamashiro S
Eurasian J Med; 2018 Feb; 50(1):6-10. PubMed ID: 29531483
[TBL] [Abstract][Full Text] [Related]
10. Acute exacerbation of idiopathic pulmonary fibrosis: lessons learned from acute respiratory distress syndrome?
Marchioni A; Tonelli R; Ball L; Fantini R; Castaniere I; Cerri S; Luppi F; Malerba M; Pelosi P; Clini E
Crit Care; 2018 Mar; 22(1):80. PubMed ID: 29566734
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of corticosteroid and intravenous cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: A propensity score-matched analysis.
Hozumi H; Hasegawa H; Miyashita K; Yasui H; Suzuki Y; Kono M; Karayama M; Furuhashi K; Hashimoto D; Enomoto N; Fujisawa T; Inui N; Nakamura Y; Yokomura K; Nakamura H; Suda T
Respirology; 2019 Aug; 24(8):792-798. PubMed ID: 30803100
[TBL] [Abstract][Full Text] [Related]
12. Acute exacerbation of idiopathic pulmonary fibrosis: shifting the paradigm.
Ryerson CJ; Cottin V; Brown KK; Collard HR
Eur Respir J; 2015 Aug; 46(2):512-20. PubMed ID: 26232481
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for acute exacerbation of idiopathic pulmonary fibrosis: A systematic review and meta-analysis.
Qiu M; Chen Y; Ye Q
Clin Respir J; 2018 Mar; 12(3):1084-1092. PubMed ID: 28332341
[TBL] [Abstract][Full Text] [Related]
14. Acute exacerbation of idiopathic pulmonary fibrosis: a 10-year single-centre retrospective study.
Yamazoe M; Tomioka H
BMJ Open Respir Res; 2018; 5(1):e000342. PubMed ID: 30397488
[TBL] [Abstract][Full Text] [Related]
15. COVID-19-Triggered Acute Exacerbation of IPF, an Underdiagnosed Clinical Entity With Two-Peaked Respiratory Failure: A Case Report and Literature Review.
Goto Y; Sakamoto K; Fukihara J; Suzuki A; Omote N; Ando A; Shindo Y; Hashimoto N
Front Med (Lausanne); 2022; 9():815924. PubMed ID: 35187001
[TBL] [Abstract][Full Text] [Related]
16. Acute exacerbation of idiopathic pulmonary fibrosis: who to treat, how to treat.
Kulkarni T; Duncan SR
Curr Pulmonol Rep; 2019 Dec; 8(4):123-130. PubMed ID: 33312849
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Role of Recombinant Human Soluble Thrombomodulin for Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
Isshiki T; Sakamoto S; Homma S
Medicina (Kaunas); 2019 May; 55(5):. PubMed ID: 31137593
[TBL] [Abstract][Full Text] [Related]
18. Differences in clinical features of acute exacerbation between connective tissue disease-associated interstitial pneumonia and idiopathic pulmonary fibrosis.
Enomoto N; Oyama Y; Enomoto Y; Yasui H; Karayama M; Kono M; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
Chron Respir Dis; 2019; 16():1479972318809476. PubMed ID: 30380910
[TBL] [Abstract][Full Text] [Related]
19. A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study).
Iwata T; Yoshino I; Yoshida S; Ikeda N; Tsuboi M; Asato Y; Katakami N; Sakamoto K; Yamashita Y; Okami J; Mitsudomi T; Yamashita M; Yokouchi H; Okubo K; Okada M; Takenoyama M; Chida M; Tomii K; Matsuura M; Azuma A; Iwasawa T; Kuwano K; Sakai S; Hiroshima K; Fukuoka J; Yoshimura K; Tada H; Nakagawa K; Nakanishi Y;
Respir Res; 2016 Jul; 17(1):90. PubMed ID: 27450274
[TBL] [Abstract][Full Text] [Related]
20. The Activities of Daily Living after an Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
Koyama K; Sakamoto S; Isshiki T; Shimizu H; Kurosaki A; Homma S
Intern Med; 2017 Nov; 56(21):2837-2843. PubMed ID: 28943534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
